Janssen Pharmaceutica
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- -
- Established
- 1953-01-01
- Employees
- 10K
- Market Cap
- -
A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis
Completed
- Conditions
- PsoriasisPlaque
- Interventions
- Other: No Intervention
- First Posted Date
- 2014-10-24
- Last Posted Date
- 2017-03-27
- Lead Sponsor
- Janssen Pharmaceutica
- Target Recruit Count
- 1131
- Registration Number
- NCT02274363
An Efficacy and Safety Study of Fentanyl Transdermal Patch in Filipino Participants With Osteoarthritis and Chronic Low Back Pain
- First Posted Date
- 2013-02-21
- Last Posted Date
- 2013-07-15
- Lead Sponsor
- Janssen Pharmaceutica
- Target Recruit Count
- 237
- Registration Number
- NCT01795898
An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar Candidiasis
- First Posted Date
- 2013-01-16
- Last Posted Date
- 2013-03-25
- Lead Sponsor
- Janssen Pharmaceutica
- Target Recruit Count
- 115
- Registration Number
- NCT01769339
A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
Completed
- Conditions
- Pneumonia, BacterialNosocomial InfectionIntraabdominal InfectionsUrinary Tract Infection
- Interventions
- First Posted Date
- 2013-01-08
- Last Posted Date
- 2013-08-09
- Lead Sponsor
- Janssen Pharmaceutica
- Target Recruit Count
- 170
- Registration Number
- NCT01763008
A Study of Safety and Effectiveness of Bendamustine Hydrochloride in Adult Filipino Patients With Chronic Lymphocytic Leukemia
- First Posted Date
- 2012-12-03
- Last Posted Date
- 2015-12-02
- Lead Sponsor
- Janssen Pharmaceutica
- Registration Number
- NCT01739491
An Efficacy, Safety and Effects on Quality of Life of Tramadol/Paracetamol as Add-on Therapy in Chronic Osteoarthritis
Phase 4
Completed
- Conditions
- Osteoarthritis
- Interventions
- Drug: Tramadol/Paracetamol (APAP)Drug: Non-Tramadol/APAP
- First Posted Date
- 2012-11-19
- Last Posted Date
- 2013-02-12
- Lead Sponsor
- Janssen Pharmaceutica
- Target Recruit Count
- 473
- Registration Number
- NCT01728246
- Locations
- 🇵ðŸ‡
Janssen Philippines, Paranaque City, Metro Manila, Philippines
A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients
- First Posted Date
- 2012-11-14
- Last Posted Date
- 2015-12-02
- Lead Sponsor
- Janssen Pharmaceutica
- Registration Number
- NCT01726348
A Safety and Effectiveness Study of Prolonged Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Chronic Non-Cancer Pain
- First Posted Date
- 2012-11-01
- Last Posted Date
- 2015-12-02
- Lead Sponsor
- Janssen Pharmaceutica
- Registration Number
- NCT01719588
A Safety and Effectiveness Study of Immediate Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Acute Non-Cancer Pain
- First Posted Date
- 2012-11-01
- Last Posted Date
- 2015-09-28
- Lead Sponsor
- Janssen Pharmaceutica
- Registration Number
- NCT01719601
Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer
- First Posted Date
- 2012-09-25
- Last Posted Date
- 2015-12-02
- Lead Sponsor
- Janssen Pharmaceutica
- Registration Number
- NCT01692483
© Copyright 2025. All Rights Reserved by MedPath